相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis
Jong Kyong Kim et al.
MOLECULAR ONCOLOGY (2020)
Discovery of novel elongator protein 2 inhibitors by compound library screening using surface plasmon resonance
Chang-Peng Xu et al.
RSC ADVANCES (2019)
Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways
Annalisa Palmieri et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2019)
A small-molecule inhibitor of the ubiquitin activating enzyme for cancer treatment
Marc L. Hyer et al.
NATURE MEDICINE (2018)
Thymoquinone challenges UHRF1 to commit auto-ubiquitination: a key event for apoptosis induction in cancer cells
Abdulkhaleg Ibrahim et al.
Oncotarget (2018)
Drug resistance in multiple myeloma
Pawel Robak et al.
CANCER TREATMENT REVIEWS (2018)
Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma
Caterina Musolino et al.
MEDIATORS OF INFLAMMATION (2017)
Berberine binds RXRα to suppress β-catenin signaling in colon cancer cells
H. Ruan et al.
ONCOGENE (2017)
UHRF1: The key regulator of epigenetics and molecular target for cancer therapeutics
Harsimran Sidhu et al.
TUMOR BIOLOGY (2017)
E3 ubiquitin ligases in cancer and implications for therapies
Dong Wang et al.
CANCER AND METASTASIS REVIEWS (2017)
Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase
Xiaoyang Dai et al.
CLINICAL CANCER RESEARCH (2017)
Berberine protects rat heart from ischemia/reperfusion injury via activating JAK2/STAT3 signaling and attenuating endoplasmic reticulum stress
Guo-long Zhao et al.
ACTA PHARMACOLOGICA SINICA (2016)
Signalling pathways in UHRF1-dependent regulation of tumor suppressor genes in cancer
Mahmoud Alhosin et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2016)
Novel agents in the treatment of multiple myeloma: a review about the future
Leonard Naymagon et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
Multiple myeloma epidemiology and survival: A unique malignancy
Dickran Kazandjian
SEMINARS IN ONCOLOGY (2016)
Hemi-methylated DNA opens a closed conformation of UHRF1 to facilitate its histone recognition
Jian Fang et al.
NATURE COMMUNICATIONS (2016)
Berberine Suppresses Cyclin D1 Expression through Proteasomal Degradation in Human Hepatoma Cells
Ning Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Ubiquitin E3 ligase UHRF1 regulates p53 ubiquitination and p53-dependent cell apoptosis in clear cell Renal Cell Carcinoma
Jian Ma et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Smad3 Couples Pak1 With the Antihypertrophic Pathway Through the E3 Ubiquitin Ligase, Fbxo32
Hoyee Tsui et al.
HYPERTENSION (2015)
Multiple myeloma maintenance therapy: A review of the pharmacologic treatment
Brandon R. Shank et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2015)
Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine
Xiaochuang Luo et al.
BMC SYSTEMS BIOLOGY (2014)
Berberine induces apoptosis in human multiple myeloma cell line U266 through hypomethylation of p53 promoter
Yanwei Qing et al.
CELL BIOLOGY INTERNATIONAL (2014)
Luteolin Induces Apoptosis in BE Colorectal Cancer Cells by Downregulating Calpain, UHRF1, and DNMT1 Expressions
Mounira Krifa et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2014)
Set9, NF-kappa B, and microRNA-21 mediate berberine-induced apoptosis of human multiple myeloma cells
Hai-yan Hu et al.
ACTA PHARMACOLOGICA SINICA (2013)
Berberine induces selective apoptosis through the AMPK-mediated mitochondrial/caspase pathway in hepatocellular carcinoma
Xiaolong Yang et al.
MOLECULAR MEDICINE REPORTS (2013)
Uhrf1-dependent H3K23 ubiquitylation couples maintenance DNA methylation and replication
Atsuya Nishiyama et al.
NATURE (2013)
The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein
D. Guan et al.
ONCOGENE (2013)
Berberine Inhibits Proliferation and Down-Regulates Epidermal Growth Factor Receptor through Activation of Cbl in Colon Tumor Cells
Lihong Wang et al.
PLOS ONE (2013)
Berberine Targets AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF and Cytochrome-c/Caspase Signaling to Suppress Human Cancer Cell Growth
Lingyi Fu et al.
PLOS ONE (2013)
Anisomycin suppresses Jurkat T cell growth by the cell cycle-regulating proteins
Chunyan Yu et al.
PHARMACOLOGICAL REPORTS (2013)
Anti-CD47 antibodies promote phagocytosis and inhibit the growth of human myeloma cells
D. Kim et al.
LEUKEMIA (2012)
Biologic Impact of Proteasome Inhibition in Multiple Myeloma Cells-From the Aspects of Preclinical Studies
Teru Hideshima et al.
SEMINARS IN HEMATOLOGY (2012)
SPR Biosensing in Crude Serum Using Ultralow Fouling Binary Patterned Peptide SAM
Olivier R. Bolduc et al.
ANALYTICAL CHEMISTRY (2010)
Proteasome inhibitors in the treatment of multiple myeloma
J. J. Shah et al.
LEUKEMIA (2009)
Berberine modifies cysteine 179 of IκBα kinase, suppresses nuclear factor-κB-regulated antiapoptotic gene products, and potentiates apoptosis
Manoj K. Pandey et al.
CANCER RESEARCH (2008)
Frequent engagement of the classical and alternative NF-κB pathways by diverse genetic abnormalities in multiple myeloma
Christina M. Annunziata et al.
CANCER CELL (2007)
The molecular classification of multiple myeloma
Fenghuang Zhan et al.
BLOOD (2006)
Berberine -: antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells
Silvia Letasiova et al.
CANCER LETTERS (2006)
Risk factors and kinetics of thrombocytopenia associated with bortezomib for relapsed, refractory multiple myeloma
S Lonial et al.
BLOOD (2005)
分享论文
